Aphria Inc. (TSX:APHA) Disappoints: Is the Stock Price Attractive Today?

Aphria Inc.’s (TSX:APHA)(NYSE:APHA) stock price took a big hit, as the company reported higher revenue but a whopping loss as it took a writedown and tackled rising costs.

question marks written reminders tickets

Image source: Getty Images

I have long written about the problem with cannabis stocks and their valuations and the expectations that are built into them.

I’ve also written about the strong likelihood that higher-than-expected spending, shareholder dilution, and slower-than-expected revenue growth will likely be very detrimental to stock prices.

The industry, cycle, and growth are in their early stages.

Aphria (TSX:APHA)(NYSE:APHA) reported its third-quarter 2019 earnings this week, and we saw all of these things, with Aphria stock plummeting almost 15%.

Revenue increased less than expected, growing 240% versus last quarter to $73.5 million, and EPS dropped to a net loss of $0.43 versus net income of $0.22 last quarter.  And even if we adjust for the writedown of the Latin American asset, Aphria’s net loss was still a hefty $0.20 per share.

General and administrative expenses increased due to the company’s expansion efforts, and while these expansion plans are a necessary expense for long-term growth and prosperity, we can see them impacting the bottom line here.

Looking ahead to next quarter, management has given us guidance to revenue and expenses being at similar levels as the company works on its long-term expansion plans and consequently takes this hit in the short term.

I’m all for that, but this means that investors need to be prepared for continued short-term volatility and weakness.

Cannabis stocks are down on this disappointing result, which saw EPS miss expectations by a significant degree and sales miss by 12%.

And while the company is arguing that its production and packaging issues are temporary, these issues were clearly not being priced into the stock. Though the company has 2.4 million square feet of production capacity, and this production is being completely revamped, switching it from manual to automated, is a positive, the market has reacted negatively.

Though this investment will ultimately bring down costs significantly, there remains a lack of visibility, so downside risk remains big.

In closing

Aphria is targeting annualized revenue of $500 million by the end of this calendar year, and $1 billion in sales by the end of the 2020 calendar year.

I would look at these disappointing results from Aphria and its consequent stock price weakness as the beginning of the stock adjusting to the realities of what the future holds for the company, which is both great and not so great.

As time goes on and the risks and uncertainties are lessened, cannabis stocks will increasingly be valued on financials and clear strategic progress.

This time is coming.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has no position in any of the stocks mentioned.

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »

A cannabis plant grows.
Cannabis Stocks

Can Aurora Cannabis Stock Recover in 2024?

Aurora Cannabis stock is down 99% from all-time highs but remains a high-risk bet, despite its cheap valuation.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

The Best Cannabis Stock to Buy Right Now

This cannabis stock has jumped 30% in the last few months, with even more growth on the way – all…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Down 99% From All-Time Highs, Is Canopy Growth Stock a Good Buy Right Now?

Canopy Growth stock is a high-risk investment due to its negative profit margins and challenging liquidity position.

Read more »

Marijuana plant and cannabis oil bottles isolated
Stocks for Beginners

Aurora Cannabis’ Reverse Stock Split: Is the Stock a Buy Today?

Cannabis stock Aurora (TSX:ACB) is consolidating shares once again, but what does this mean for investors?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Where Will Cannabis Stocks Be in 10 Years?

Cannabis stocks could see a huge shift upwards should marijuana be rescheduled in the U.S., but you can still buy…

Read more »